Polifeprosan 20
- Generic Name
- Polifeprosan 20
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 90409-78-2
- Unique Ingredient Identifier
- S40C40DA21
- Background
Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).
- Associated Conditions
- -
- Associated Therapies
- -
O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
Phase 1
Completed
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- National Cancer Institute (NCI)
- Registration Number
- NCT00004892
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath